Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report

INTRODUCTION: Erythrodermic psoriasis (EP) is a rare and severe form of psoriasis that affects 1% to 2.25% of patients, increasing mortality risk. To date, very few therapies have been approved for the treatment of this condition. Recently, biological therapies that specifically target inflammatory...

Descripción completa

Detalles Bibliográficos
Autor principal: Carriero, Martino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902433/
https://www.ncbi.nlm.nih.gov/pubmed/35309848
http://dx.doi.org/10.33393/dti.2022.2355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902433/
https://www.ncbi.nlm.nih.gov/pubmed/35309848
http://dx.doi.org/10.33393/dti.2022.2355

Ejemplares similares